By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

IntelGenx Corp. 

6425 Abrams Ville Street

Laurent  Quebec  H4S 1X9  Canada
Phone: 514-331-7440 Fax: 514-331-0436


SEARCH JOBS


Industry
Pharmaceutical






Company News
IntelGenx Corp. Grants Stock Options 12/9/2014 11:04:15 AM
IntelGenx Corp. Grants Extension Of Marketing Exclusivity In The U.S. To Edgemont Pharmaceuticals, LLC. Of Forfivo XL(R) 12/5/2014 10:40:15 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Announce Acceptance For Review Of European Marketing Application For RIZAPORT For Migraines 12/1/2014 10:30:25 AM
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014 9:16:05 AM
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/25/2014 10:17:30 AM
IntelGenx Corp. To Present At Singular Research's Best Of The Uncovered 2014 NYC Fall Conference 11/20/2014 2:01:19 PM
IntelGenx Corp. Announces Successful Clinical Study For Schizophrenia 11/3/2014 8:46:42 AM
IntelGenx Corp. Founder Returns As President And CEO 10/2/2014 6:40:58 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Submit European Marketing Authorization Application For Migraine Drug RIZAPORT® (Formerly RHB-103) 10/1/2014 9:12:10 AM
IntelGenx Corp. To Present At Singular Research 9th Annual Best Of The Uncovereds Conference 9/17/2014 10:09:41 AM
12345678910...
//-->